FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095627191> ?p ?o ?g. }

• W2095627191 endingPage "18" @default.
• W2095627191 startingPage "13" @default.
• W2095627191 abstract "There is considerable interest in the development of a non-surgical method to terminate early pregnancy. During the three weeks immediately following the first missed menstrual period, several prostaglandin (PG) analogs such as sulprostone, gemeprost and 9-methylene PGE2 have been used to terminate the pregnancy. Prostaglandins, however, at the doses required to induce disruption of the conceptus cause gastrointestinal side effects and uterine pain which are more severe than those subsequent to vacuum aspiration. Treatment with the antiprogestin, mifepristone counteracts the effects of progesterone in pregnancy and thus prevents maintenance of the pregnancy. Mifepristone administered alone causes termination of the pregnancy in most, but not all, cases. In addition to removing the influence of progesterone, mifepristrone also induces regular uterine contractions and significantly increased the sensitivity of the uterus to PG analogs. Mifepristone (50 mg/day) followed by an intramuscular injection of a low dose, (0.25 mg), of sulprostone (approximately 1/6 of the dose of prostaglandin necessary to induce abortion if used alone) was highly effective in terminating early pregnancy, causing complete abortion in 94% of cases. Gastrointestinal side effects were rare and uterine pain significantly less common than if PG analogs were used alone. Subsequently the combination of mifepristone and vaginal administration of gemeprost (0.5–1.0 mg) has been shown to be equally effective (1). Ideally, the PG analog would be administered orally rather than by injection or vaginal administration. Preliminary data indicate that 9-methylene PGE2 but not PGE2 may be suitable for this purpose in combination with mifepristone. In a naturally occurring spontaneous abortions a decreased influence of progesterone and increased local production of PGF2α are thought to result in uterine contractions and hence termination of pregnancy. Thus sequential therapy with antiprogestin and a PG analog may mimic the physiological events of a spontaneous abortion." @default.
• W2095627191 created "2016-06-24" @default.
• W2095627191 creator A5008076365 @default.
• W2095627191 creator A5087710002 @default.
• W2095627191 date "1989-01-01" @default.
• W2095627191 modified "2023-09-25" @default.
• W2095627191 title "PROSTAGLANDINS AND ANTIPROGESTINS" @default.
• W2095627191 cites W1541708495 @default.
• W2095627191 cites W174638640 @default.
• W2095627191 cites W1964022820 @default.
• W2095627191 cites W1982627872 @default.
• W2095627191 cites W2001099922 @default.
• W2095627191 cites W2004526104 @default.
• W2095627191 cites W2009407274 @default.
• W2095627191 cites W2025216110 @default.
• W2095627191 cites W2029602174 @default.
• W2095627191 cites W2037710592 @default.
• W2095627191 cites W2044785965 @default.
• W2095627191 cites W2054254905 @default.
• W2095627191 cites W2073127739 @default.
• W2095627191 cites W2076186743 @default.
• W2095627191 cites W2097816399 @default.
• W2095627191 cites W2122991103 @default.
• W2095627191 doi "https://doi.org/10.1111/j.1600-0412.1989.tb08043.x" @default.
• W2095627191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2618597" @default.
• W2095627191 hasPublicationYear "1989" @default.
• W2095627191 type Work @default.
• W2095627191 sameAs 2095627191 @default.
• W2095627191 citedByCount "6" @default.
• W2095627191 countsByYear W20956271912013 @default.
• W2095627191 crossrefType "journal-article" @default.
• W2095627191 hasAuthorship W2095627191A5008076365 @default.
• W2095627191 hasAuthorship W2095627191A5087710002 @default.
• W2095627191 hasConcept C126322002 @default.
• W2095627191 hasConcept C2776106523 @default.
• W2095627191 hasConcept C2778826759 @default.
• W2095627191 hasConcept C2779066055 @default.
• W2095627191 hasConcept C2779234561 @default.
• W2095627191 hasConcept C2779526769 @default.
• W2095627191 hasConcept C2780664492 @default.
• W2095627191 hasConcept C54355233 @default.
• W2095627191 hasConcept C71924100 @default.
• W2095627191 hasConcept C86803240 @default.
• W2095627191 hasConceptScore W2095627191C126322002 @default.
• W2095627191 hasConceptScore W2095627191C2776106523 @default.
• W2095627191 hasConceptScore W2095627191C2778826759 @default.
• W2095627191 hasConceptScore W2095627191C2779066055 @default.
• W2095627191 hasConceptScore W2095627191C2779234561 @default.
• W2095627191 hasConceptScore W2095627191C2779526769 @default.
• W2095627191 hasConceptScore W2095627191C2780664492 @default.
• W2095627191 hasConceptScore W2095627191C54355233 @default.
• W2095627191 hasConceptScore W2095627191C71924100 @default.
• W2095627191 hasConceptScore W2095627191C86803240 @default.
• W2095627191 hasIssue "S149" @default.
• W2095627191 hasLocation W20956271911 @default.
• W2095627191 hasLocation W20956271912 @default.
• W2095627191 hasOpenAccess W2095627191 @default.
• W2095627191 hasPrimaryLocation W20956271911 @default.
• W2095627191 hasRelatedWork W1968463576 @default.
• W2095627191 hasRelatedWork W2026826010 @default.
• W2095627191 hasRelatedWork W2031253530 @default.
• W2095627191 hasRelatedWork W2051527207 @default.
• W2095627191 hasRelatedWork W2095627191 @default.
• W2095627191 hasRelatedWork W2286309563 @default.
• W2095627191 hasRelatedWork W2291599676 @default.
• W2095627191 hasRelatedWork W2294496959 @default.
• W2095627191 hasRelatedWork W2413639235 @default.
• W2095627191 hasRelatedWork W2413994836 @default.
• W2095627191 hasVolume "68" @default.
• W2095627191 isParatext "false" @default.
• W2095627191 isRetracted "false" @default.
• W2095627191 magId "2095627191" @default.
• W2095627191 workType "article" @default.